"pharmacomodulation" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "pharmaco",
        "3": "modulation"
      },
      "expansion": "pharmaco- + modulation",
      "name": "prefix"
    }
  ],
  "etymology_text": "From pharmaco- + modulation.",
  "forms": [
    {
      "form": "pharmacomodulations",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "~"
      },
      "expansion": "pharmacomodulation (countable and uncountable, plural pharmacomodulations)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with pharmaco-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 August 14, “Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells”, in PLOS ONE, →DOI:",
          "text": "Interestingly, the p-chloro- and p-trifluoromethyl-phenyl monophenols 10 and 11 retained activity (EC 50 = 4.0 ± 1.4 μM and 12.4 ± 6.9 μM, respectively) with an excellent selectivity versus proliferating TG1 GSCs, suggesting that pharmacomodulation is possible at this position.",
          "type": "quote"
        }
      ],
      "glosses": [
        "The modification of existing pharmaceuticals by replacing substituents etc"
      ],
      "id": "en-pharmacomodulation-en-noun-lKKa4Lcd",
      "links": [
        [
          "modification",
          "modification"
        ],
        [
          "pharmaceutical",
          "pharmaceutical"
        ],
        [
          "substituent",
          "substituent"
        ]
      ],
      "tags": [
        "countable",
        "uncountable"
      ]
    }
  ],
  "word": "pharmacomodulation"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "pharmaco",
        "3": "modulation"
      },
      "expansion": "pharmaco- + modulation",
      "name": "prefix"
    }
  ],
  "etymology_text": "From pharmaco- + modulation.",
  "forms": [
    {
      "form": "pharmacomodulations",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {
        "1": "~"
      },
      "expansion": "pharmacomodulation (countable and uncountable, plural pharmacomodulations)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English countable nouns",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with pharmaco-",
        "English terms with quotations",
        "English uncountable nouns",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015 August 14, “Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells”, in PLOS ONE, →DOI:",
          "text": "Interestingly, the p-chloro- and p-trifluoromethyl-phenyl monophenols 10 and 11 retained activity (EC 50 = 4.0 ± 1.4 μM and 12.4 ± 6.9 μM, respectively) with an excellent selectivity versus proliferating TG1 GSCs, suggesting that pharmacomodulation is possible at this position.",
          "type": "quote"
        }
      ],
      "glosses": [
        "The modification of existing pharmaceuticals by replacing substituents etc"
      ],
      "links": [
        [
          "modification",
          "modification"
        ],
        [
          "pharmaceutical",
          "pharmaceutical"
        ],
        [
          "substituent",
          "substituent"
        ]
      ],
      "tags": [
        "countable",
        "uncountable"
      ]
    }
  ],
  "word": "pharmacomodulation"
}